Clinical Trial Update: Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating quadruple oral combination therapy for Type 2 Diabetes Mellitus as add-on after failure of an oral triple regimen, using TZD or SGLT-2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitor
• TZD

Snippet

Sponsor: Yonsei University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED